Skip to main content

Table 2 Patient characteristics according to mortality

From: Assessment of biochemical markers in the early post-burn period for predicting acute kidney injury and mortality in patients with major burn injury: comparison of serum creatinine, serum cystatin-C, plasma and urine neutrophil gelatinase-associated lipocalin

 

Survivors (n = 50)

Non-survivors (n = 40)

Total patients (n = 90)

  

Early deaths (n = 17)

Late deaths (n = 23)

Total deaths (n = 40)

 

Age, mean ± SD

45.4 ± 14.2

54.5 ± 13.3

54.1 ± 14.5

54.3 ± 13.8

49.3 ± 13.5

Sex, male:female (%)

43:7 (86:14)

15:2 (88:12)

19:4 (83:17)

34:6 (85:15)

77:13 (86:14)

Mode, FB:SB:EB:CB:SKB (%)

40:1:5:3:1 (80:2:10:6:2)

15:1:1:0:0 (88:6:6:0:0)

20:1:1:0:1 (87:4:4:0:4)

35:2:2:0:1 (88:5:5:0:3)

75:3:7:3:2 (83:3:8:3:2)

TBSA burned, mean % ± SD

41.9 ± 15.2

82.9 ± 17.4

65.7 ± 18.4

73.0 ± 19.7

55.7 ± 23.2

Third-degree burn wound, mean % ± SD

28.0 ± 13.4

77.0 ± 24.2

54.4 ± 22.3

64.0 ± 25.5

44.0 ± 26.5

Inhalation injury, n (%)

11 (22)

13 (76.4)

5 (21.7)

18 (45)

29 (32.2)

Mechanical ventilation, n (%)

12 (24)

17 (100)

23 (100)

40 (100)

52 (57.8)

Rhabdomyolysis, n (%)

10 (20)

15 (88.2)

10 (43.4)

25 (62.5)

35 (38.9)

AKI, n (%)

17 (34)

17 (100)

21 (91)

38 (95)

55 (61.1)

Early AKI, n (%) (%)

7 (14)

17 (100)

6 (26)

23 (57.5)

31 (33.3)

Post-burn day of AKI, days, mean ± SD

14.0 ± 15.9

1.0 ± 0.0

11.2 ± 9.8

6.6 ± 8.9

9.1 ± 12.1

Cause of AKI, BS:RD:SS:MD, n

4:3:0:10

16:1:0:0

3:3:14:1

19:4:14:1

23:7:14:11

CRRT, n (%)

5 (10)

0 (0)

17 (73.9)

17 (42.5)

22 (24.4)

RIFLE (R:I:F) starting CRRT, n

0:0:5

 

2:8:7

2:8:7

2:8:12

Post-burn day of CRRT, days, mean ± SD

10.8 ± 7.6

 

14.9 ± 9.9

14.9 ± 9.9

14.0 ± 9.4

Duration of CRRT, days, mean ± SD

9.2 ± 4.4

 

7.0 ± 10.4

7.0 ± 10.4

7.5 ± 9.3

Early vasopressor, n (%)

1 (2)

17 (100)

7 (30.4)

24 (60)

25 (27.8)

Vasopressor, n (%)

7 (14)

17 (100)

23 (100)

40 (100)

47 (52.2)

Sepsis, n (%)

10 (20)

0 (0)

20 (86.9)

20 (50)

30 (33.3)

Cultured organism in blood (P:A:M:O:N), n

3:4:1:1:1

 

13:3:0:1:3

13:3:0:1:3

16:7:1:2:4

Post-burn day of sepsis, days, mean ± SD

17.5 ± 13.9

 

13.0 ± 8.6

13.0 ± 8.6

14.5 ± 10.6

LOS, days, mean ± SD

66.0 ± 28.2

2.5 ± 1.1

19.8 ± 15.1

12.4 ± 14.3

42.2 ± 35.2

  1. Early deaths, non-survivors who developed burn shock in spite of fluid resuscitation and died within 3 days of burn injury; Late deaths, mortality caused by other than burn shock; FB, flame burn; SB, scalding burn; EB, electrical burn; CB, chemical burn; SKB, spark burn; AKI: acute kidney injury; Early AKI, AKI that developed within 5 day of injury; BS, burn shcok; RD, rhabdomyolysis; SS, septic shock; MD, medication; TBSA, total body surface area: CRRT, continuous renal replacement therapy; RIFLE, risk, injury, failure, sustained loss, and end-stage kidney disease; RIFLE (R:I:F), patient RIFLE criteria for patients starting CRRT; Early vasopressor, vasopressor infusion due to shock within 1 day of admission; Cultured organism: organism cultured in blood from paitents with sepsis; P: Pseudomonas aeruginosa; A: Acinetobacter baumanii; M: multi-resistant Staphylococcus aureus; O: Other organisms; N: blood culture negative; LOS, length of hospital stay.
Back to article page

Critical Care

ISSN: 1364-8535